MedRhythms, a Portland-based company that combines sensors, neuroscience and music to help people recover from neurologic injury or disease, announced Friday it raised $5 million in an oversubscribed Series A Financing round. The company stated in a news release that it intended to raise $4 million but due to substantial interest it raised the offering to $5.3 million. By the time of Friday’s announcement, it had raised $5 million. This investment will allow MedRhythms to develop and launch a patent-pending digital therapeutics platform that focuses on building evidence-based, FDA-approved, prescription products for people with neurologic injuries and diseases to improve and measure walking. While the first product on the platform focuses on the post-stroke population, the pipeline includes products for Parkinson’s disease, multiple sclerosis, aging-In-place and traumatic brain injury. Read more here.
Related Posts
University of Maine recruiting homeowners for tick surveys
ORONO, Maine — With tick season upon us, researchers at the University of Maine want to know what Mainers are doing...
Maine’s oldest bioscience symposium turns 50 on MDI
Students and accomplished science leaders share research on Mt. Desert Island This April 20 marked the 50th anniversary meeting of the...
Husson University students, faculty share projects at 13th annual Research Showcase
BANGOR, Maine — Today marked Husson University’s 13th annual Research and Scholarship Day. Students and faculty members at Husson shared the...